NCT07785726

Brief Summary

Describe clinical characteristic, peripheral blood parameters and bone marrow examination in pancytopenia patients and Analyze etiology of pancytopenia and study the outcomes regarding duration of hospital stay.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Aug 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Aug 2026Oct 2028

Study Start

First participant enrolled

August 1, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

August 20, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 25, 2026

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Expected
Last Updated

August 25, 2026

Status Verified

August 1, 2026

Enrollment Period

Same day

First QC Date

August 20, 2026

Last Update Submit

August 22, 2026

Conditions

Keywords

pancytopenia

Outcome Measures

Primary Outcomes (1)

  • Proportion of underlying etiologies of pancytopenia

    Percentage of study participants diagnosed with each etiology of pancytopenia based on clinical, hematological, and pathological evaluation

    At the time of patient enrollment and initial diagnostic workup

Secondary Outcomes (2)

  • Frequency of clinical features and hematological parameters in pancytopenia patients

    At baseline

  • Distribution of bone marrow pathological findings

    At baseline

Study Arms (1)

Pancytopenia Cases

Patients presenting with clinical and laboratory features of pancytopenia who are admitted to or evaluated at Assiut University Hospitals. This group includes individuals undergoing routine clinical, hematological, and pathological assessments to identify the underlying causes of their condition.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients of different age groups and both sexes who present with clinical manifestations and laboratory findings suggestive of pancytopenia, attending the inpatient departments or outpatient clinics at Assiut University Hospitals.

You may qualify if:

  • Adults aged ≥ 18 years suffering from pancytopenia. Pancytopenia defined as a hematologic condition characterized by a decrease in all three peripheral blood cell lines. It is characterized by a hemoglobin value of less than 12 g/dL in women and 13 g/dL in men, platelets of less than 150,000 per mcL, and leukocytes of less than 4000 per ml (or absolute neutrophil count of less than 1800 per ml), (Chiravuri, Shalini, and Orlando De Jesus. "Pancytopenia.". StatPearls Publishing, 2023).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pancytopenia

Condition Hierarchy (Ancestors)

CytopeniaHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Mai Mostafa mohamed kamal, Prof

    Assiut University

    STUDY CHAIR

Central Study Contacts

rana mohamed zain, MBBCh

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident physician

Study Record Dates

First Submitted

August 20, 2026

First Posted

August 25, 2026

Study Start

August 1, 2026

Primary Completion

August 1, 2026

Study Completion (Estimated)

October 1, 2028

Last Updated

August 25, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

The individual participant data will not be shared to protect patient privacy and maintain confidentiality in accordance with the institutional ethical guidelines of Assiut University. Only aggregate study results and statistical summaries will be available through publication.